318 related articles for article (PubMed ID: 34131566)
1. Thymoquinone anticancer activity is enhanced when combined with royal jelly in human breast cancer.
Moubarak MM; Chanouha N; Abou Ibrahim N; Khalife H; Gali-Muhtasib H
World J Clin Oncol; 2021 May; 12(5):342-354. PubMed ID: 34131566
[TBL] [Abstract][Full Text] [Related]
2. Low Doses of Thymoquinone and Ferulic Acid in Combination Effectively Inhibit Proliferation of Cultured MDA-MB 231 Breast Adenocarcinoma Cells.
Al-Mutairi A; Rahman A; Rao MS
Nutr Cancer; 2021; 73(2):282-289. PubMed ID: 32223348
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H
Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone enhances the antioxidant and anticancer activity of Lebanese propolis.
AlDreini S; Fatfat Z; Abou Ibrahim N; Fatfat M; Gali-Muhtasib H; Khalife H
World J Clin Oncol; 2023 May; 14(5):203-214. PubMed ID: 37275937
[TBL] [Abstract][Full Text] [Related]
5. Concurrent Reactive Oxygen Species Generation and Aneuploidy Induction Contribute to Thymoquinone Anticancer Activity.
Al-Hayali M; Garces A; Stocks M; Collins H; Bradshaw TD
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500570
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone Could Increase The Efficacy of Tamoxifen Induced Apoptosis in Human Breast Cancer Cells: An In Vitro Study.
Ganji-Harsini S; Khazaei M; Rashidi Z; Ghanbari A
Cell J; 2016; 18(2):245-54. PubMed ID: 27540530
[TBL] [Abstract][Full Text] [Related]
7. Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells.
Khan A; Aldebasi YH; Alsuhaibani SA; Khan MA
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1153-1160. PubMed ID: 31030489
[TBL] [Abstract][Full Text] [Related]
8. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells.
Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D
Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A
Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741
[TBL] [Abstract][Full Text] [Related]
10. Effect of Thymoquinone on P53 Gene Expression and Consequence Apoptosis in Breast Cancer Cell Line.
Dastjerdi MN; Mehdiabady EM; Iranpour FG; Bahramian H
Int J Prev Med; 2016; 7():66. PubMed ID: 27141285
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone-induced antitumor and apoptosis in human lung adenocarcinoma cells.
Samarghandian S; Azimi-Nezhad M; Farkhondeh T
J Cell Physiol; 2019 Jul; 234(7):10421-10431. PubMed ID: 30387147
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of thymoquinone and melatonin against breast cancer implanted in mice.
Odeh LH; Talib WH; Basheti IA
J Cancer Res Ther; 2018 Jun; 14(Supplement):S324-S330. PubMed ID: 29970684
[TBL] [Abstract][Full Text] [Related]
13. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
[TBL] [Abstract][Full Text] [Related]
14. Modulation of gene expression by thymoquinone conjugated zinc oxide nanoparticles arrested cell cycle, DNA damage and increased apoptosis in triple negative breast cancer cell line MDA-MB-231.
Sjs B; K K; A P; P H; B SR; S S
Drug Dev Ind Pharm; 2021 Dec; 47(12):1943-1951. PubMed ID: 35510706
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative and Apoptosis-Inducing Activities of Thymoquinone in Lymphoblastic Leukemia Cell Line.
Soltani A; Pourgheysari B; Shirzad H; Sourani Z
Indian J Hematol Blood Transfus; 2017 Dec; 33(4):516-524. PubMed ID: 29075062
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD-L1 in MDA-MB-231 Triple-Negative Breast Cancer Cells.
Adinew G; Messeha SS; Badisa R; Taka E; Soliman KFA
FASEB J; 2022 May; 36 Suppl 1():. PubMed ID: 35723877
[TBL] [Abstract][Full Text] [Related]
17. The comparison of anticancer activity of thymoquinone and nanothymoquinone on human breast adenocarcinoma.
Dehghani H; Hashemi M; Entezari M; Mohsenifar A
Iran J Pharm Res; 2015; 14(2):539-46. PubMed ID: 25901162
[TBL] [Abstract][Full Text] [Related]
18. Chebulinic acid inhibits MDA-MB-231 breast cancer metastasis and promotes cell death through down regulation of SOD1 and induction of autophagy.
Sharma A; Mishra T; Thacker G; Mishra M; Narender T; Trivedi AK
Cell Biol Int; 2020 Dec; 44(12):2553-2569. PubMed ID: 32902904
[TBL] [Abstract][Full Text] [Related]
19. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
Şakalar Ç; İzgi K; İskender B; Sezen S; Aksu H; Çakır M; Kurt B; Turan A; Canatan H
Tumour Biol; 2016 Apr; 37(4):4467-77. PubMed ID: 26500095
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells.
Zheng M; Mei Z; Junaid M; Tania M; Fu J; Chen HC; Khan MA
Anticancer Agents Med Chem; 2022; 22(6):1111-1118. PubMed ID: 34170813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
